TY - JOUR
T1 - 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization
T2 - A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
AU - Lawton, Jennifer S.
AU - Tamis-Holland, Jacqueline E.
AU - Bangalore, Sripal
AU - Bates, Eric R.
AU - Beckie, Theresa M.
AU - Bischoff, James M.
AU - Bittl, John A.
AU - Cohen, Mauricio G.
AU - Dimaio, J. Michael
AU - Don, Creighton W.
AU - Fremes, Stephen E.
AU - Gaudino, Mario F.
AU - Goldberger, Zachary D.
AU - Grant, Michael C.
AU - Jaswal, Jang B.
AU - Kurlansky, Paul A.
AU - Mehran, Roxana
AU - Metkus, Thomas S.
AU - Nnacheta, Lorraine C.
AU - Rao, Sunil V.
AU - Sellke, Frank W.
AU - Sharma, Garima
AU - Yong, Celina M.
AU - Zwischenberger, Brittany A.
N1 - Publisher Copyright:
© 2022 Lippincott Williams and Wilkins. All rights reserved.
PY - 2022/1/18
Y1 - 2022/1/18
N2 - AIM: The guideline for coronary artery revascularization replaces the 2011 coronary artery bypass graft surgery and the 2011 and 2015 percutaneous coronary intervention guidelines, providing a patient-centric approach to guide clinicians in the treatment of patients with significant coronary artery disease undergoing coronary revascularization as well as the supporting documentation to encourage their use. METHODS: A comprehensive literature search was conducted from May 2019 to September 2019, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, the Cochrane Collaboration, CINHL Complete, and other relevant databases. Additional relevant studies, published through May 2021, were also considered. STRUCTURE: Coronary artery disease remains a leading cause of morbidity and mortality globally. Coronary revascularization is an important therapeutic option when managing patients with coronary artery disease. The 2021 coronary artery revascularization guideline provides recommendations based on contemporary evidence for the treatment of these patients. The recommendations present an evidence-based approach to managing patients with coronary artery disease who are being considered for coronary revascularization, with the intent to improve quality of care and align with patients' interests.
AB - AIM: The guideline for coronary artery revascularization replaces the 2011 coronary artery bypass graft surgery and the 2011 and 2015 percutaneous coronary intervention guidelines, providing a patient-centric approach to guide clinicians in the treatment of patients with significant coronary artery disease undergoing coronary revascularization as well as the supporting documentation to encourage their use. METHODS: A comprehensive literature search was conducted from May 2019 to September 2019, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, the Cochrane Collaboration, CINHL Complete, and other relevant databases. Additional relevant studies, published through May 2021, were also considered. STRUCTURE: Coronary artery disease remains a leading cause of morbidity and mortality globally. Coronary revascularization is an important therapeutic option when managing patients with coronary artery disease. The 2021 coronary artery revascularization guideline provides recommendations based on contemporary evidence for the treatment of these patients. The recommendations present an evidence-based approach to managing patients with coronary artery disease who are being considered for coronary revascularization, with the intent to improve quality of care and align with patients' interests.
KW - AHA Scientific Statements
KW - angiogram
KW - angiography
KW - angioplasty
KW - arterial graft
KW - cardiac surgery, stent(s)
KW - coronary artery bypass graft surgery
KW - coronary atherosclerosis
KW - internal mammary artery graft
KW - internal thoracic artery graft
KW - left ventricular dysfunction
KW - multivessel PCI
KW - myocardial infarction
KW - myocardial revascularization
KW - non-ST-segment-elevated myocardial infarction
KW - percutaneous coronary intervention
KW - percutaneous transluminal coronary angioplasty
KW - post-bypass
KW - saphenous vein graft
KW - vein graft lesions
UR - http://www.scopus.com/inward/record.url?scp=85122146693&partnerID=8YFLogxK
U2 - 10.1161/CIR.0000000000001038
DO - 10.1161/CIR.0000000000001038
M3 - Review article
C2 - 34882435
AN - SCOPUS:85122146693
SN - 0009-7322
VL - 145
SP - E18-E114
JO - Circulation
JF - Circulation
IS - 3
ER -